HomeInsightsStock Comparison

Accent Microcell Ltd vs Krebs Biochemicals Industries Ltd Stock Comparison

Accent Microcell Ltd vs Krebs Biochemicals Industries Ltd Stock Comparison

Last Updated on: May 03, 2026

Key Highlights

  • The Latest Trading Price of Accent Microcell Ltd is ₹ 425.35 as of 30 Apr 15:30 . The P/E Ratio of Accent Microcell Ltd changed from 17.1 on March 2024 to 12.1 on March 2025 . This represents a CAGR of -15.88% over 2 yearsThe P/E Ratio of Krebs Biochemicals & Industries Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Accent Microcell Ltd changed from ₹ 517.13 crore on March 2024 to ₹ 401.61 crore on March 2025 . This represents a CAGR of -11.87% over 2 yearsThe Market Cap of Krebs Biochemicals & Industries Ltd changed from ₹ 174.33 crore on March 2021 to ₹ 144 crore on March 2025 . This represents a CAGR of -3.75% over 5 years The revenue of Accent Microcell Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Krebs Biochemicals & Industries Ltd for the Dec '25 is ₹ 7.28 crore as compare to the Sep '25 revenue of ₹ 4.17 crore. This represent the growth of 74.58% The ebitda of Accent Microcell Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Krebs Biochemicals & Industries Ltd for the Dec '25 is ₹ 0.3 crore as compare to the Sep '25 ebitda of ₹ -2.79 crore. This represent the decline of -110% The net profit of Accent Microcell Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Krebs Biochemicals & Industries Ltd changed from ₹ -5.17 crore to ₹ -3.13 crore over 7 quarters. This represents a CAGR of -24.93% The Dividend Payout of Accent Microcell Ltd changed from 8.96 % on March 2021 to 6.36 % on March 2025 . This represents a CAGR of -6.63% over 5 yearsThe Dividend Payout of Krebs Biochemicals & Industries Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Accent Microcell Ltd

  • Accent Microcell Limited was originally incorporated on April 10, 2012 as a Private Limited Company as 'Accent Microcell Private Limited' with the Registrar of Companies, Gujarat.
  • The Company converted from a Private Limited Company to Public Limited Company and , the name was changed to Accent Microcell Limited' and a Fresh Certificate of Incorporation was issued on December 23, 2022 by the Registrar of Companies, Ahmedabad. Presently, the Company manufacture Microcrystalline Cellulose (MCC) consisting Spray Dryer / Spin Flash Dried.
  • The Company is engaged in manufacturing of the high-quality cellulose-based excipients which predominantly find application in the Pharmaceutical, Nutraceutical, Food, Cosmetic and other industries. With 2 state-of-art manufacturing facilities located in Pirana (Unit -I) and Dahej SEZ (Unit -II).

About Krebs Biochemicals & Industries Ltd

  • Krebs Biochemicals & Industries Ltd (Formerly Krebs Biochemicals Ltd), promoted by R T Ravi in 1991 is engaged in the manufacture of Active Pharmaceutical Ingredients(API) through Fermentation process, one among very few in the world to do the same. Krebs develops commercially viable biotech processes for application in medicine, agriculture and industry.
  • Undertaking contract manufacturing for large pharmaceutical and multinational companies and developing products for sale in global markets, the Company possesses expertise and infrastructure in chemical synthesis, fermentation and enzymatic technologies. KBIL which commenced commercial operations in the year 1994 with an installed capacity of 60 TPA has now grown to 150 TPA. KBL went to public with an IPO in 1994. During 2001-02, the company launched Vitamin C(I P Grade) through Fermentation Process.

FAQs for the comparison of Accent Microcell Ltd and Krebs Biochemicals & Industries Ltd

Which company has a larger market capitalization, Accent Microcell Ltd or Krebs Biochemicals & Industries Ltd?

Market cap of Accent Microcell Ltd is 1,020 Cr while Market cap of Krebs Biochemicals & Industries Ltd is 129 Cr

What are the key factors driving the stock performance of Accent Microcell Ltd and Krebs Biochemicals & Industries Ltd?

The stock performance of Accent Microcell Ltd and Krebs Biochemicals & Industries Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Accent Microcell Ltd and Krebs Biochemicals & Industries Ltd?

As of May 3, 2026, the Accent Microcell Ltd stock price is INR ₹425.35. On the other hand, Krebs Biochemicals & Industries Ltd stock price is INR ₹60.12.

How do dividend payouts of Accent Microcell Ltd and Krebs Biochemicals & Industries Ltd compare?

To compare the dividend payouts of Accent Microcell Ltd and Krebs Biochemicals & Industries Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions